CRCA vs. RAVI
CRCA (ProShares Ultra CRCL) and RAVI (FlexShares Ultra-Short Income ETF) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while RAVI is a Ultrashort Bond fund actively managed by FlexShares. Both are actively managed. At a correlation of -0.12, they often move in opposite directions. CRCA charges 0.95%/yr vs 0.25%/yr for RAVI.
Performance
CRCA vs. RAVI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -50.19% return, which is significantly lower than RAVI's 1.69% return.
CRCA
- 1D
- -10.71%
- 1M
- -58.97%
- YTD
- -50.19%
- 6M
- -54.34%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
RAVI
- 1D
- 0.05%
- 1M
- 0.30%
- YTD
- 1.69%
- 6M
- 1.79%
- 1Y
- 4.37%
- 3Y*
- 5.17%
- 5Y*
- 3.54%
- 10Y*
- 2.67%
CRCA vs. RAVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -50.19% | -84.67% |
RAVI FlexShares Ultra-Short Income ETF | 1.69% | 1.93% |
Correlation
The correlation between CRCA and RAVI is -0.12, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 7, 2025 | -0.12 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. RAVI — Risk / Return Rank
CRCA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
RAVI
CRCA vs. RAVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and FlexShares Ultra-Short Income ETF (RAVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRCA | RAVI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 5.23 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 37.51 | — |
| Martin ratioReturn relative to average drawdown | — | 214.85 | — |
Loading charts...
Drawdowns
CRCA vs. RAVI - Drawdown Comparison
The maximum CRCA drawdown since its inception was -94.31%, which is greater than RAVI's maximum drawdown of -3.72%. Use the drawdown chart below to compare losses from any high point for CRCA and RAVI.
Loading charts...
Drawdown Indicators
| CRCA | RAVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.31% | -3.72% | -90.59% |
Max Drawdown (1Y)Largest decline over 1 year | — | -0.12% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -0.36% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -3.28% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -3.72% | — |
Current DrawdownCurrent decline from peak | -92.37% | 0.00% | -92.37% |
Average DrawdownAverage peak-to-trough decline | -71.73% | -0.17% | -71.56% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 0.02% | — |
Volatility
CRCA vs. RAVI - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | RAVI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 0.13% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 0.31% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 194.67% | 0.41% | +194.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 194.67% | 1.41% | +193.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 194.67% | 1.28% | +193.39% |
CRCA vs. RAVI - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is higher than RAVI's 0.25% expense ratio.
Dividends
CRCA vs. RAVI - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 3.48%, less than RAVI's 4.37% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
CRCA ProShares Ultra CRCL | 3.48% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RAVI FlexShares Ultra-Short Income ETF | 4.37% | 4.59% | 5.34% | 4.55% | 1.70% | 0.90% | 1.29% | 2.53% | 2.22% | 1.28% | 0.90% |
Frequently Asked Questions
CRCA and RAVI have a correlation of -0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, RAVI is cheaper at 0.25% per year. The better choice depends on whether you care most about return, fees, risk, or income.
RAVI is cheaper with a 0.25% expense ratio, compared with 0.95% for CRCA.
RAVI has the higher dividend yield at 4.37%, compared with 3.48% for CRCA.
CRCA is categorized as Leveraged Equities, while RAVI is Ultrashort Bond. They also come from different issuers: ProShares and FlexShares. Their fees differ too: 0.95% for CRCA and 0.25% for RAVI.
Find the right allocation for CRCA and RAVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer